Articles From: RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014 to UPDATE: 6 ways to travel on the cheap this summer


RedHill received positive results from a comparative bioavailability clinical trial which included 20 healthy volunteers In light of the positive results, and subject to regulatory requirements, the Company plans to submit, during the third quarter of this year, a European marketing application for RHB-102 for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, extended release oral pill formulation of the anti-emetic oncology support drug ondansetron RedHill is also pursuing a new undisclosed indication for RHB-102, which may significantly expand its potential market, with a Phase III study planned to commence in the U.S. later this year TEL-AVIV, Israel, April 30, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014 investment picks
http://media.marketwire.com/attachments/201303/135777_enteromedicslogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110791&ProfileId=051205&sourceType=1 ST.
Sign-up for EnteroMedics Reports First Quarter 2014 Financial Results investment picks
MATTHEWS, N.C. , April 30, 2014 /PRNewswire/ -- PokerTek, Inc. (Nasdaq: PTEK) ("PokerTek") announced today that it has entered into a definitive agreement and plan of merger with Multimedia Games, Inc., a subsidiary of Multimedia Games Holding Company, Inc. (Nasdaq: MGAM) (together, "Multimedia Games"), pursuant to which Multimedia Games has agreed to acquire PokerTek at a price of $1.35 per share in cash.
Sign-up for PokerTek, Inc. Announces Agreement To Be Acquired By Multimedia Games investment picks
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 1:30 PM ET.
Sign-up for Stemline Therapeutics to Present at the Deutsche Bank 39th Annual Health Care Conference investment picks
- First-quarter 2014 operating earnings of $1.04 per share compared to guidance of 85 cents to $1.00 per share - First-quarter 2014 GAAP earnings of 65 cents per share - Company affirms 2014 operating earnings guidance of $3.35 to $3.65 per share RICHMOND, Va.
Sign-up for Dominion Announces First-Quarter 2014 Earnings investment picks
MANCHESTER, Conn., April 30, 2014 (GLOBE NEWSWIRE) -- Lydall Performance Materials, a division of Lydall, Inc. (NYSE:LDL) , announces the launch of best-in-class filtration membranes for vent filters used in single-use biopharmaceutical applications.
Sign-up for Lydall Introduces New Solupor(R) HF Membrane for Vent Filter Applications investment picks
Appointment of Eileen M.
Sign-up for Ocean Power Technologies Announces Changes to Board of Directors investment picks
STAMFORD, Conn., April 30, 2014 (GLOBE NEWSWIRE) -- Star Gas Partners, L.P. (the "Partnership" or "Star") (NYSE:SGU) , a home energy distributor and services provider specializing in heating oil, today announced that it will release its fiscal 2014 second quarter results after the close of trading on May 7, 2014.
Sign-up for Star Gas Partners, L.P. to Host Fiscal 2014 Second Quarter Webcast and Conference Call May 8, 2014 investment picks
http://media.marketwire.com/attachments/201404/74683_foxconnlogo.jpg http://media.marketwire.com/attachments/201212/109000_36797_HP_Blue_RGB_72_MD.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110899&ProfileId=051205&sourceType=1 PALO ALTO, CA and TAIPEI, TAIWAN --
Sign-up for HP and Foxconn Announce Joint Venture Agreement Delivering New Class of Servers for Fast-Growing Service Provider Market investment picks
2014/4/30
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0942468001&sourceType=1 http://www.ccnmatthews.com/logos/20070524-QBR_200.jpg MONTREAL, QUEBEC --
Sign-up for Media Advisory: Quebecor Inc.'s Financial Results for First Quarter 2014-Conference Call investment picks
2014/4/30
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G015094-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/4/29/11G015094/Scotiabank-logo-780364326799.jpg TORONTO, ON--(Marketwired - April 30, 2014) - Global vehicle sales remained strong in March, climbing 6% above the previous year, according to the Scotiabank Global Auto Report released today.
Sign-up for Scotiabank: Geographic Diversification Is Crucial for Auto Exporters investment picks
Achieves Record Revenue of $80.9 Million; Improves Gross Margin 200 Basis Points Sequentially MILPITAS, Calif.
Sign-up for ISSI Announces Second Fiscal Quarter 2014 Results investment picks
BEIJING , April 30, 2014 /PRNewswire/ -- Recon Technology, Ltd.
Sign-up for Recon Technology Attends Sinopec Seminars on Shale Gas Project investment picks
http://media.marketwire.com/attachments/201106/27974_TITANlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110981&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Titan Pharmaceuticals Provides Overview of Upcoming Clinical Study of Probuphine Following Clear Guidance From the FDA investment picks
CINCINNATI , April 30, 2014 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV) , a leading provider of laser vision correction services under the Lasik Plus ® brand, today announced financial and operating results for the three months ended March 31, 2014 .
Sign-up for LCA-Vision Reports First Quarter Financial Results investment picks
BEIJING , April 30, 2014 /PRNewswire-FirstCall/ -- Yongye International, Inc. (NASDAQ: YONG) ("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced that it has established the close of business on May 5, 2014 as the record date for its special meeting of stockholders to consider and vote on, among other things, the proposal to approve the previously announced Agreement and Plan of Merger, dated as of September 23, 2013 , as amended on April 9, 2014 (the "Amended Merger Agreement"), among the Company, Full Alliance International Limited, Yongye International Limited ("Parent") and Yongye International Merger Sub Limited ("Merger Sub"). Under the terms of the Amended Merger Agreement, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving company after the
Sign-up for Yongye International, Inc. Sets Record Date for Special Meeting of Stockholders to Approve Amended Merger Agreement investment picks
ALISO VIEJO, Calif.
Sign-up for Microsemi to Present at Jefferies 2014 Global Technology, Media and Telecom Conference investment picks
SAN DIEGO, April 30, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) , a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced its scheduled presentation to provide an overview of the company's programs and outlook at the Deutsche Bank 39 th Annual Health Care Conference at 2:50 p.m. ET on Wednesday, May 7, 2014, in Boston.
Sign-up for Conatus Pharmaceuticals to Present at Deutsche Bank Health Care Conference investment picks
PORTSMOUTH, N.H. , April 30, 2014 /PRNewswire/ -- Sprague Resources LP (NYSE: SRLP) ("Sprague") today announced that it will release its first quarter financial results before the market opens on Wednesday, May 14, 2014 .
Sign-up for Sprague Resources LP to Host First Quarter 2014 Earnings Conference Call on May 14, 2014 investment picks
2014/4/30
- Base revenue grows 12.1% over 1Q13 to $117.6 million - Adjusted per share loss of $0.131 compared to loss of $0.24 in 1Q13 - Cash flow from operations improves 81.5% - Sequential debt reduction of $4.4 million [1] Excluding $0.4 million charge for legal and related defense expenses.
Sign-up for USA Truck Reports Improved First Quarter 2014 Results investment picks
PETALUMA, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (Nasdaq:ENPH) , announced today the company will be presenting at the following upcoming financial conferences: The Jefferies 2014 Global Technology, Media and Telecom presentation will be webcast live and/or archived on Enphase Energy's investor relations website at http://investor.enphase.com .
Sign-up for Enphase Energy to Present at Jefferies, Deutsche Bank and FBR Conferences investment picks
LEXINGTON, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS) , an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced the issuance of U.S. Patent No.
Sign-up for Curis Announces U.S. Patent Issuance Covering CUDC-907 Composition-of-Matter investment picks
Time Warner Inc. (NYSE:TWX) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.3175 per share of Common Stock, payable in cash on June 15, 2014 to stockholders of record on May 31, 2014.
Sign-up for Time Warner Declares Regular Quarterly Cash Dividend investment picks
Professional market billings increase 26% over prior year third quarter and up 36% over comparative trailing twelve month period driven by solid traction from inside and online sales channel and joint marketing alliance wins Pharmaceutical manufacturer market billings increase 56% over prior year third quarter and up 52% over comparative trailing twelve month period Strong growth and increased demand in the Environmental market Balance sheet remains solid with a cash balance of $14.4 million and working capital of $15.9 million Outlook for the June 2014 quarter looks strong with expected customer billings of at least $7.0 million Five new Patient Support Programs with Pharmaceutical Manufacturers to be launched over second half of calendar 2014 and during calendar 2015 HOUSTON, April 30, 2014 (GLOBE NEWSWIRE) -- Sharps Compliance Corp.
Sign-up for Sharps Compliance Achieves 19.6% Increase in Fiscal Year 2014 Nine Month Revenue investment picks
2014/4/30
By Daniel Inman HONG KONG--Japanese stocks ended the day slightly higher in a choppy session on Wednesday after the Bank of Japan stood pat on policy, while Hong Kong stocks saw a sharp loss.
Sign-up for Japan leads Asian shares as BOJ stands pat investment picks
2014/4/30
By Therese Poletti, MarketWatch SAN FRANCISCO (MarketWatch) -- Even for Silicon Valley, the scandal is ugly.
Sign-up for UPDATE: Silicon Valley startup adrift as abusive CEO is fired investment picks
LEXINGTON, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS) , an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that the Company will present at the Deutsche Bank 39 th Annual Health Care Conference at 4:50 p.m. ET on May 7, 2014, in Boston.
Sign-up for Curis to Present at the Deutsche Bank 39th Annual Health Care Conference investment picks
2014/4/30
By Andrea Coombes Got a yen to hit the road this summer?
Sign-up for UPDATE: 6 ways to travel on the cheap this summer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014 to UPDATE: 6 ways to travel on the cheap this summer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry